We show that amongst patients hospitalised with COVID‐19, 19.5% have IgM autoantibodies against CD209L, and 5.9% have antibodies against CD209, whereas 6% and 5%, respectively, is the frequency of the IgG isotypes. This evidence concerns the gene CD209 and COVID-19.